Trials / Completed
CompletedNCT05055219
Conventional and Metabolomic Predictors of Prediabetes & Insulin Resistance
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 772 (actual)
- Sponsor
- University of Michigan · Academic / Other
- Sex
- All
- Age
- 8 Years – 22 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the longitudinal test performance of an array of conventional biomarkers of glycemia, including Hemoglobin A1c (HbA1c), and novel metabolomic biomarkers for identifying progression of glucose tolerance (normal to prediabetes or prediabetes to diabetes) in an overweight and obese pediatric cohort.
Conditions
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2020-02-19
- Completion
- 2020-02-19
- First posted
- 2021-09-24
- Last updated
- 2021-09-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05055219. Inclusion in this directory is not an endorsement.